From mechanisms to therapies: exploiting epigenetic and post-translational modifications of mitochondrial quality control in diabetic kidney disease
Dan-mai Zhao, Zhong-hong Yan, Yi-yang Yu, Yang-yang Zhang, Zhong-qiu Luan · 2026
Read From mechanisms to therapies: exploiting epigenetic and post-translational modifications of mitochondrial quality control in diabetic kidney disease by Dan-mai Zhao, Zhong-hong Yan, Yi-yang Yu, Yang-yang Zhang, Zhong-qiu Luan (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13194009.txt.
Description
Dan-mai Zhao and four co-authors review how control systems for cellular power plants go wrong in diabetic kidney disease, in a review paper from 2026. The kidneys burn huge amounts of energy, so their mitochondria must stay healthy. A quality control system builds new mitochondria, reshapes them, and clears worn ones.
The review focuses on two layers of fine-tuning: chemical tags on DNA and proteins, and small RNA interactions. These layers shape how the quality control system behaves and help drive the disease. The authors survey drugs and other strategies that target this regulatory web. They aim to point researchers toward more precise treatments for a leading cause of kidney failure.
Catalog record
| CREATOR | Dan-mai Zhao, Zhong-hong Yan, Yi-yang Yu, Yang-yang Zhang, Zhong-qiu Luan |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 59 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |